This is a proposal to renew funding of the Center for Drug Use and HIV Research (CDUHR) for years 21- 25. Recent advances in HIV biomedical and behavioral science have been shown to reduce HIV incidence and allow HIV-positive persons to reach near-normal lifespans. These achievements have led UNAIDS, the US and several local governments to propose strategies for ?Ending the HIV Epidemic?. Notwithstanding these successes, attaining this goal among people who use drugs (PWUD) will require addressing a number of important existing barriers. The overall theme of this renewal is ?Ending HIV/AIDS among People who use Drugs: Overcoming Challenges?. We define Ending HIV/AIDS as reducing new infections and increasing the proportion of PWUD who are virally suppressed. To accomplish this, we have identified these research priorities, which directly address the most significant challenges: (1) Devise new strategies to overcome emerging and persistent barriers to ending HIV/AIDS among PWUD. Barriers include recent increases in prescription opioid misuse, which have given rise to a new generation of heroin user and injectors, and lack of attention to the key role of substance use in new infections in men who have sex with men and heterosexuals. HIV-positive PWUD also experience disparities all along the continuum of HIV care, including delayed diagnosis, lower retention in care, delayed initiation of ART and poorer disease outcomes. (2) Conduct research on effective ways to broadly implement evidence-based interventions. HIV prevention and care programs for PWUD do not exist in many regions of the US and the rest of the world where they are needed most, and they are rarely implemented at public-health scale. (3) Develop new, innovative models of prevention and treatment interventions to address substance-use related disparities in HIV infection and treatment outcomes that take into account the complex, multilevel nature of HIV among PWUD. We have made significant changes in our scope and structure for this renewal, and we will achieve our aims through five Cores, an Administrative Core and four Research Support Cores: (1) Infectious Disease Epidemiology and Theory, (2) Transdisciplinary Research Methods, (3) Dissemination and Implementation, and (4) Pilot Projects and

Mentoring

These Cores support our research base and affiliated investigators to conduct cutting-edge science and enhance synergy across investigators from multiple disciplines, thereby leading to contributions to the field that are beyond what the individual projects could have achieved. In addition to the many successful initiatives that have been developed over CDUHR's history, new activities were added to respond to the evolving needs of our investigators. Also, in addition to our ongoing commitment to train new investigators to conduct high-impact research, we will collaborate with investigators in areas where HIV epidemics are occurring among PWUD (in rural and middle America, and in eastern Europe and Asia), building on our collective knowledge and expertise to advance toward Ending HIV/AIDS in those regions.

Public Health Relevance

A critical time has been reached in the course of the HIV epidemic, when the possibility to end HIVAIDS has been raised. Despite advances in biomedical treatments and behavioral interventions to reduce HIV incidence and its impact, people who use drugs (PWUD) have poorer outcomes. The Center provides a research infrastructure to enhance the productivity, synergy and impact of the research by affiliated investigators working to End HIV/AIDS among PWUD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA011041-24
Application #
10086432
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Chatterji, Minki
Project Start
1998-04-01
Project End
2023-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
24
Fiscal Year
2021
Total Cost
Indirect Cost
Name
New York University
Department
Social Sciences
Type
Schools of Public Health
DUNS #
041968306
City
New York
State
NY
Country
United States
Zip Code
10012
Campbell, Aimee N C; Wolff, Margaret; Weaver, Laurel et al. (2018) ""It's Never Just About the HIV:"" HIV Primary Care Providers' Perception of Substance Use in the Era of ""Universal"" Antiretroviral Medication Treatment. AIDS Behav 22:1006-1017
Uusk├╝la, Anneli; Raag, Mait; Vorobjov, Sigrid et al. (2018) Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study. Harm Reduct J 15:10
Hautala, Dane; Abadie, Roberto; Thrash, Courtney et al. (2018) Latent Risk Subtypes Based on Injection and Sexual Behavior Among People Who Inject Drugs in Rural Puerto Rico. J Rural Health 34:236-245
Whitham, Hilary K; Sansom, Stephanie L; Wejnert, Cyprian et al. (2018) Sex Practices by HIV Awareness and Engagement in the Continuum of Care Among MSM: A National HIV Behavioral Surveillance Analysis in 21 U.S. Cities. AIDS Behav 22:840-847
Combellick, Joan L; Shin, Hakdong; Shin, Dongjae et al. (2018) Differences in the fecal microbiota of neonates born at home or in the hospital. Sci Rep 8:15660
Khan, Maria R; McGinnis, Kathleen A; Grov, Christian et al. (2018) Past year and prior incarceration and HIV transmission risk among HIV-positive men who have sex with men in the US. AIDS Care :1-8
Ompad, Danielle C; Palamar, Joseph J; Krause, Kristen D et al. (2018) Reliability and Validity of a Material Resources Scale and Its Association With Depression Among Young Men Who Have Sex With Men: The P18 Cohort Study. Am J Mens Health 12:1384-1397
Pham Minh, Khue; Vallo, Roselyne; Duong Thi, Huong et al. (2018) Psychiatric Comorbidities among People Who Inject Drugs in Hai Phong, Vietnam: The Need for Screening and Innovative Interventions. Biomed Res Int 2018:8346195
Palamar, Joseph J; Salomone, Alberto; Cleland, Charles M et al. (2018) Willingness to provide a hair sample for drug testing among electronic dance music party attendees. Subst Abus :1-8
Des Jarlais, Don C; Arasteh, K; Feelemyer, J et al. (2018) Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Drug Alcohol Depend 192:74-79

Showing the most recent 10 out of 339 publications